RUBRAMIN PC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rubramin Pc, and what generic alternatives are available?
Rubramin Pc is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in RUBRAMIN PC is cyanocobalamin. There are nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rubramin Pc
A generic version of RUBRAMIN PC was approved as cyanocobalamin by PADAGIS ISRAEL on September 9th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RUBRAMIN PC?
- What are the global sales for RUBRAMIN PC?
- What is Average Wholesale Price for RUBRAMIN PC?
Summary for RUBRAMIN PC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Patent Applications: | 57 |
DailyMed Link: | RUBRAMIN PC at DailyMed |
US Patents and Regulatory Information for RUBRAMIN PC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | RUBRAMIN PC | cyanocobalamin | INJECTABLE;INJECTION | 006799-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol Myers Squibb | RUBRAMIN PC | cyanocobalamin | INJECTABLE;INJECTION | 006799-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol Myers Squibb | RUBRAMIN PC | cyanocobalamin | INJECTABLE;INJECTION | 006799-010 | Apr 28, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |